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Abstract
Parallel evolution is the independent evolution of the same phenotype or genotype in response to the same selection
pressure. There are examples of parallel molecular evolution across divergent genetic backgrounds, suggesting that
genetic background may not play an important role in determining the outcome of adaptation. Here, we measure the
influence of genetic background on phenotypic and molecular adaptation by combining experimental evolution with
comparative analysis. We selected for resistance to the antibiotic rifampicin in eight strains of bacteria from the genus
Pseudomonas using a short term selection experiment. Adaptation occurred by 47 mutations at conserved sites in rpoB,
the target of rifampicin, and due to the high diversity of possible mutations the probability of within-strain parallel
evolution was low. The probability of between-strain parallel evolution was only marginally lower, because different
strains substituted similar rpoBmutations. In contrast, we found that more than 30% of the phenotypic variation in the
growth rate of evolved clones was attributable to among-strain differences. Parallel molecular evolution across strains
resulted in divergent phenotypic evolution because rpoB mutations had different effects on growth rate in different
strains. This study shows that genetic divergence between strains constrains parallel phenotypic evolution, but had little
detectable impact on the molecular basis of adaptation in this system.
Key words: antibiotic resistance, experimental evolution, comparative biology, adaptation, Pseudomonas, selection
experiment.
Introduction
Although adaptation ultimately depends on the stochastic
appearance of beneficial mutations, there are many examples
of repeated adaptation from independent populations, line-
ages, or species. These are often referred to as homoplasies,
and can be divided into whether they are examples of parallel,
convergent, or reversal evolution (Rokas and Carroll 2008).
Parallel evolution can be defined as repeated adaptation from
independently evolved populations in response to similar se-
lection pressures, where the ancestral state is initially con-
served across populations (Zhang and Kumar 1997). There
are examples of this from both the real world and from lab-
oratory experiments, particular for antibiotic resistance (e.g.,
Jatsenko et al. 2010; Lieberman et al. 2011; Wong and Kassen
2011; Wong et al. 2012; Dettman et al. 2013) but also for many
other traits (e.g., Woods et al. 2006; Ostrowski et al. 2008;
Rokas and Carroll 2008; Lieberman et al. 2011; Dettman
et al. 2013). Interestingly, many of these examples of parallel
molecular evolution are occurring across genetic back-
grounds—in other words, parallel evolution where the
target of selection is conserved, but there are otherwise
many differences between the genomes of these organisms.
This suggests that genetic background plays a relatively unim-
portant role in determining the outcome of adaptation at the
molecular level, but direct tests of this idea are lacking. The
impact of parallel molecular evolution on phenotypic adap-
tation is also unclear. There is growing evidence that epistasis
is pervasive (Costanzo et al. 2010; Khan et al. 2011; Breen et al.
2012), suggesting that parallel molecular evolution may
lead to divergent phenotypic evolution across genetic back-
grounds, but tests of this idea are also lacking.
The lack of estimates of the influence of genetic back-
ground on parallel evolution can be at least partially explained
by the different methods which have used to study parallel-
ism within versus between genetic backgrounds (Wood et al.
2005). Parallel evolution within a particular genetic back-
ground has often been experimentally tested using laboratory
or greenhouse experimental evolution (reviewed in Wood
et al. 2005). In contrast, parallel evolution between different
genetic backgrounds has generally been explored using phy-
logenetic or other comparative methods (reviewed in Wood
et al. 2005). There have been few attempts to incorporate
comparative biology into experimental evolution (but see
Wichman et al. 2000; Holder and Bull 2001; Bollback and
Huelsenbeck 2009; Nguyen et al. 2012). By integrating these
two differing methodologies, it is possible to directly test the
role of genetic background in determining the trajectory of
adaptation. If genetic differences between backgrounds play
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an inconsequential role in adaptation, we would expect the
same selection pressure to result in very similar outcomes
in different backgrounds. In this scenario, the likelihood of
parallel evolution within-backgrounds should be equal to
the likelihood of parallel evolution between-backgrounds.
In contrast, if genetic background is key a determinant of
evolutionary potential, we would expect adaptation to be
highly contingent on genetic background. In this scenario,
the likelihood of within-background parallelism should be
much greater than the likelihood of between-background
parallelism.
Here, we use comparative experimental evolution to test
whether genetic differences between strains of bacteria influ-
ence their adaptation to a common selection pressure.
Specifically, we attempted to test whether parallel evolution
was more likely between two populations of the same strain,
than between two populations from different strains. To
achieve this, we extend existing approaches by selecting for
resistance to the antibiotic rifampicin in eight different strains
of bacteria from seven different species within the genus
Pseudomonas. These strains of Pseudomonas show substantial
genetic divergence, ensuring that our selection experiment
was initiated with meaningfully different genetic back-
grounds. For example, the genomes of the Pseudomonads
in our study system vary in size between 4.6 and 7.1 Mb
and contain between approximately 4,100 genes and 6,100
genes ( €Ozen and Ussery 2012). Crucially, in spite of this di-
vergence, all of these strains can be cultured in the lab under
the same set of conditions, thereby removing any potentially
confounding effect of other environmental differences on
adaptation.
We challenged bacteria with evolving resistance to the
antibiotic rifampicin, which binds to a highly conserved
pocket on the -subunit of RNA polymerase (rpoB).
Resistance to high doses of rifampicin typically evolves by
point mutations in rpoB, which result in alterations to the
structure of the rifampicin binding pocket. Previous work in
Escherichia coli (e.g., Garibyan et al. 2003), Mycobacterium
tuberculosis (e.g., Sandgren et al. 2009), Pseudomonas aerugi-
nosa (e.g., Jatsenko et al. 2010), and Staphylococcus aureus
(e.g., Wichelhaus et al. 2002) has shown that at least 75 dif-
ferent mutations in rpoB can drive the evolution of rifampicin
resistance. Although some mutations have been reported for
a range of species, there are also many strain-specific muta-
tions. Even when the same mutation is reported in different
strains, its frequency can be markedly variable. Parallel evolu-
tion is therefore possible but not universal, and consequently
the evolution of rifampicin resistance is a convenient model
for testing hypothesis about parallel molecular evolution.
Previous work has also shown that different resistance muta-
tions that are found within the same strain show substantial
variation in rifampicin tolerance (MacLean and Buckling
2009), competitive ability (Gagneux et al. 2006; MacLean
and Buckling 2009), and gene expression (Carata et al.
2009). This implies that each rifampicin resistance mutation
represents a substantially different adaptation to rifampicin.
Because rigorous tests of the prevalence of parallel evolu-
tion require large sample sizes, we used an experimental
design that involved selecting a large number of populations
with the antibiotic rifampicin. After selection for rifampicin
resistance, we isolated 75 independently evolved rifampicin-
resistant clones from each strain. We then quantified the
phenotypic outcome of selection, by measuring the growth
rate of clones in the presence of rifampicin, and the genetic
outcome of selection, by sequencing rpoB in our evolved
clones.
Results
Molecular Basis of Adaptation
To determine the frequency of parallel evolution between
different genetic backgrounds, we selected 75 rifampicin-
resistant mutants in each of eight strains of Pseudomonas
(fig. 1). Then, to determine the genetic basis of resistance
evolution, we sequenced regions of rpoB that have been pre-
viously implicated in rifampicin resistance. Using this candi-
date gene approach, we discovered a single mutation per
clone. Although we cannot exclude the possibility that our
rifampicin-resistant clones carried second site mutations in
other parts of their genome, several lines of evidence suggest
that the importance of these mutations was minimal. First,
the duration of our selection experiment was short, and the
resistant clones that we isolated were separated from their
common sensitive ancestors by a maximum of&30 genera-
tions. Given that the genomic mutation rate of bacteria is on
the order of 0.003 mutations/genome/generation (Drake
1991), there was little opportunity for the clones that we
isolated to acquire greater than one mutation. If second site
mutations are important for resistance evolution, then differ-
ent clones with the same rpoB mutation should vary pheno-
typically. However, we found no significant variation in
growth rate among clones with the same resistance mutation
(fully nested ANOVA (clone nested within mutation nested
within strain): F461,555 = 0.799, P= 0.994).
In total, we found 47 different mutations (fig. 2). All but
two of these were single nucleotide polymorphisms resulting
in an amino acid substitution. The other two mutations were
FIG. 1. Phylogeny of the Pseudomonas strains used in this study, as
determined by the sequence of 55 highly conserved housekeeping
genes. Branch lengths are proportional to genetic distance and all
nodes on this phylogeny are strongly supported with at least 99%
confidence, as determined by an approximate log-likelihood ratio test
(Furio and Maclean, in preparation).
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FIG. 2. Frequency of rifampicin resistance mutations across eight strains of Pseudomonas. Base pair changes are numbered according to the sequence of
rpoB in P. aeruginosa PAO1, and rows that are grouped together represent mutations in the same codon. Colors on the heat map indicate the frequency
of each mutation, with red the most frequent. Blacked-out squares indicate an amino acid substitution would not be possible in a particular strain as a
result of single nucleotide substitution.
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a deletion of a single amino acid and the insertion of a single
amino acid, both occurring in P. mendocina. Due to the highly
conserved nature of rpoB, all 47 of these mutations were
theoretically possible for six of our strains, based on the an-
cestral nucleotide sequence. However, for P. mendocina and
P. stutzeri, the mutation at nucleotide 1,736 would result in a
different amino acid substitution than in the other strains,
due to a preexisting mutation at another base within the
same codon. The distribution of mutations across strains
was notably uneven. Most mutations were found in only
one (n= 17) or two strains (n= 12), whereas only four muta-
tions were common to all strains (fig. 2). Mutations found
in only a small number of strains tended to be rarer than
mutations common across strains and were usually found in
only a single clone (mean 1.6 clones per mutation found
in only one strain). In contrast, mutations that were found
across all strains tended to occur at a high frequency, with
47% of clones possessing the most common mutation,
A1562G (fig. 2).
To determine the likelihood of parallel molecular evolution
within strain, we calculated the probability that two rifampi-
cin-resistant clones evolved from the same strain share the
same rpoB mutation. We found that the probability of within-
strain parallelism varied widely, with values ranging between
0.096 for P. fulva to 0.647 for P. putida. However, the phylo-
genetically corrected mean probability of parallel molecular
evolution between populations of the same strain was 0.225,
implying that within-strain parallelism is relatively rare. To
calculate the probability of between-strain parallel evolution,
we first calculated Gst’, which measures the proportion of
variance in rpoB mutations explained by differences between
strain. We found that Gst’ is equal to 0.147, which implies
that differences between strain only account for 14.7%
of the variance in rpoB mutation frequency. Therefore, the
mean similarity of mutation spectra across strains is
10.147 = 0.853, which implies that between-strain parallel
evolution is almost as likely as within-strain parallel evolution.
Therefore the probability of parallel evolution between pop-
ulations of different strain can be estimated as the probability
of within-strain parallel evolution (0.225) multiplied by the
similarity of mutation spectra (0.853), which is equal to 0.19.
In other words, we find that genetic divergence between
strains has only a minor effect on the probability of parallel
evolution in this system.
It is notable however that there are differences between
strains with regards to their mutation spectrums. Clustering
the mutation spectrums using squared Euclidian distances
reveals that there are essentially two spectrums of resistance
mutations across our eight strains (fig. 3A). The mutation
spectra of P. putida, P. protegens, P. fluorescens spp., and
P. aeruginosa are characterized by a relatively low diversity
of adaptive mutations and the dominance of a single
hotspot mutation (A1562G), whereas P. fulva, P. stutzeri,
and P. mendocina are characterized by a greater diversity of
mutations and a reduced prevalence of the A1562G muta-
tion. It is notable that this clustering of mutation spectra into
two discreet groups is not a reflection of phylogeny. Instead,
the three strains with reduced frequencies of the hotspot
mutation also have notably smaller genomes than the
other strains. Indeed, there is a significant and phylogeneti-
cally independent association between genome size and mu-
tation spectrum (fig. 3B; correlation between phylogenetic
independent contrasts (PICs): r= 0.855, P< 0.01, df = 6).
Specifically, the genome sizes of P. fulva (4.8 Mb), P. stutzeri
(4.6 Mb), and P. mendocina (5.3 Mb) are noticeably smaller
than the genome sizes of our other isolates (46.2 Mb in
all cases).
Parallel Phenotypic Evolution
Having established a clear pattern of parallel evolution at
the molecular level, we wished to see if this was reflected
at the phenotypic level. To measure the phenotypic out-
come of evolution, we assayed the growth rate of each
evolved clone in culture medium supplemented with rifam-
picin at the relevant selective dose. To directly compare
the growth rates of evolved clones from different strains,
we standardize the growth rate for each clone relative to
the growth rate of its rifampicin-sensitive ancestor in the
absence of rifampicin. Therefore a growth rate equal to
one implies that an evolved clone grows as quickly in the
FIG. 3. (A) Rifampicin-resistant mutation spectrums cluster into two
distinct groups. Dendrogram clustered according to squared Euclidian
distances of mutation spectra. (B) Genome size significantly and phy-
logenetically independently correlates with mutation spectrum across
Pseudomonas. Each point represents a separate PIC, and therefore sig-
nifies the absolute amount of change in a character between neighbor-
ing strains or nodes.
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presence of rifampicin as its ancestor grows in the absence of
rifampicin.
We found that the growth rate of evolved clones varied
significantly between strains (fig. 4A, one-way ANOVA:
F7,590 = 38.44, P< 0.001), and differences between strains ex-
plained 31.3% of the variance in growth rate. This result
implies that genetic background plays a bigger role in pheno-
typic evolution than in genetic evolution in this system. There
are two potential causes of this variation. First, if resistance
mutations have the same effect on growth rate irrespective
of the genetic background in which they occur, then strains
that have similar mutation spectra should show similar mean
levels of adaptation. However, we did not find a significant
correlation between mutation spectrum and mean growth
rate across strains (fig. 4B; correlation of PICs for mutation
spectrum and growth rate: r= 0.084, P= 0.843, df = 6).
Alternatively, it is possible for resistance phenotypes to
diverge because the same mutations have different effects
on growth rate in different strains. According to this expla-
nation, growth rate is determined by epistatic interactions
between rpoB mutations and the rest of the genome.
To directly test for epistasis, we compared the growth rate
of the hotspot mutation A1562G across all strains. This mu-
tation is the only mutation that was isolated at least twice
in each strain, and 47% of the evolved clones have this
mutation. The A1562G mutation had highly epistatic effects
(fig. 4C; one-way ANOVA: F7,274 = 32.56, P< 0.001), with
growth rates ranging from 0.97 in P. aeruginosa to 0.50 in
P. mendocina. Although this analysis cannot tell us whether
other mutations are epistatic, given that this mutation rep-
resents 47% of all isolates, we can conclude that epistasis
has a major effect on adaptation in our system.
Discussion
We investigated how genetic background influences the evo-
lution of rifampicin resistance in eight different strains
of Pseudomonas in a common selective environment. We
found that parallel evolution was more common within-
strain than between-strain, implying that genetic background
has a detectable impact on adaptation in this system. The
magnitude of this effect varied, however, as genetic back-
ground accounted for approximately 14% of the variation
in the genetic basis of resistance and approximately 30% of
the variation in the phenotype of resistant mutants.
Overall, parallel molecular evolution between populations
of the same strain was not very common, largely due to the
high diversity of mutations that can result in rifampicin resis-
tance. Fundamentally, the reason parallel evolution was de-
tected is because mutations leading to high level rifampicin
resistance are only possible in a single domain of rpoB
(Campbell et al. 2001). However, despite this highly conserved
and relatively narrow target of selection, the molecular basis
of adaptation was highly diverse. We identified 47 different
mutations leading to rifampicin resistance, a level of diversity
common to other studies of rifampicin resistance (e.g.,
Garibyan et al. 2003; Jatsenko et al. 2010). Nevertheless,
although 46 of these mutations were possible in all strains,
only four mutations were actually isolated from all strains,
and most mutations were only isolated once in each strain.
The most plausible explanation for this pattern is simple
chance; given the large number of possible mutations and
only 75 mutants per strain, the probability of any individual
mutation arising is low. The exceptions to this are mutations
at nucleotide 455. These mutations were relatively common
in P. mendocina and P. aeruginosa (mean frequency = 15.3%),
but despite being possible, they were never isolated in any
of the other strains. It is therefore conceivable that these
mutations only confer resistance on these two genetic
FIG. 4. (A) Boxplot of fitness effects of rifampicin resistance mutations
across eight strains of Pseudomonas, based on relative growth rate in the
presence of rifampicin. Each set of mutants is standardized to the
growth rate of the relevant ancestral strain growing in the absence of
rifampicin. (B) No significant correlation between mutation spectrum
and mean growth rate in the presence of rifampicin. Each point repre-
sents a separate PIC, and therefore signifies the absolute amount
of change in a character between neighboring strains or nodes.
(C) Growth rate of the A1562G mutation growing in the presence of
rifampicin. Bars show mean growth rate ( standard error) for all iso-
lates carrying the A1562G mutation in each strain. Values are again
standardized to the growth rate of the relevant ancestral strain growing
in the absence of rifampicin.
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backgrounds. This has been previously reported for clinically
isolated rifampicin-resistant M. tuberculosis, where certain
mutations only confer resistance on specific genetic back-
grounds (Zaczek et al. 2009). However, it has not been previ-
ously identified for this particular locus within rpoB, so we
cannot be certain that it is definitely occurring here.
We identified two alternative mutation spectra, which
differ primarily in terms of the frequency of a hotspot muta-
tion, A1562G. Specifically, in the strains with larger genomes
the frequency of A1562G is high, whereas in strains with small
genomes the frequency of A1562G is low. It has been previ-
ously demonstrated in E. coli that knocking-out genes in-
volved in DNA mismatch-repair can result in a wide variety
of alterations to mutation spectrum (Garibyan et al. 2003).
Crucially, the frequency of this particular hotspot mutation
has been shown to increase approximately 3-fold when mutS
is knocked-out (Garibyan et al. 2003). However, mutS is found
in all strains of Pseudomonas used in this study, and none of
these strains have a high mutation rate as would be expected
from a mutS knockout (Vogwill T, unpublished data). Of
course gene presence might not be the major driver of mu-
tation spectrum, and instead relative gene expression might
be crucial. For example, it has been shown that alterations to
temperature can also have pronounced effects on mutation
spectrum (Jatsenko et al. 2010). This is again a particular rel-
evant example, as altering the temperature altered the fre-
quency of the A1562G mutation in P. aeruginosa. As
environmental conditions were controlled in our study, this
is arguing that the strains with smaller genomes show differ-
ential regulation of DNA-repair genes in response to the same
environmental stimuli.
In line with previous work, we found evidence that the
fitness effects of rifampicin resistance mutations are epistatic
(MacLean et al. 2010; Hall and MacLean 2011; Angst and Hall
2013; Borrell et al. 2013). Although we only analyzed the fit-
ness effects of the most common mutation, this mutation
played a key role in phenotypic evolution because almost 50%
of isolates carried this mutation. Hypothetically, the cause of
this epistasis could be that in different strains the same mu-
tation has differential effects of the binding of rifampicin to
rpoB. If so, this epistasis is therefore reflecting the same mu-
tation conferring higher levels of resistance in some strains
than others. However, given that the rifampicin binding
pocket is highly conserved across all strains (Campbell et al.
2001), it seems highly unlikely that this is the case. Moreover,
these mutations have epistatic effects on fitness in the ab-
sence of rifampicin (Vogwill T, unpublished data). It is there-
fore more likely that the same mutation has different fitness
costs in different strains. As the cost of rifampicin resistance is
known to depend on demand for RNA-polymerase (Hall et al.
2011), a simple explanation is therefore that demand RNA-
polymerase varies between strains. However, rpoB mutations
are also known to be highly pleiotropic (Xu et al. 2002; Gao
et al. 2013; Hall 2013; Rodriguez-Verdugo et al. 2013). Under
laboratory conditions, rpoB mutations can be selected by a
variety of selection pressures, such as temperature
(Rodriguez-Verdugo et al. 2013) and aging colonies
(Wrande et al. 2008). Although rpoB itself is highly conserved,
these other cellular systems are far less so. It is therefore pos-
sible that the epistasis we detected is a result of complex
interplay between rpoB mutations and the expression of
genes involved in multiple other cellular processes.
One limitation of this study is that the duration of the
selection experiment was short by microbial standards (<30
generations). On a purely practical level, the short duration of
the experiment was necessitated by the number of popula-
tions used (&3,800), but it is important to speculate about
the extent to which time influenced the outcome of our
study. It could be argued that the influence of genetic back-
ground would have been further erased by continued selec-
tion for adaptation. For example, Travisano et al. (1995) found
that the influence of evolutionary history on fitness declined
during adaptation. However, it could be argued that genetic
background should become more important for longer adap-
tive walks, particular with regards to molecular evolution
(Harms and Thornton 2013). In the case of rifampicin, studies
in M. tuberculosis (Casali et al. 2012, Comas et al. 2012; de Vos
et al. 2013) and Salmonella typhimurium (Brandis et al. 2012;
Brandis and Hughes 2013) have shown that compensatory
adaptation often occurs by mutations in rpoC, which encodes
another subunit of RNA-polymerase. Intriguingly, approxi-
mately 25% of sites in rpoC which have been implicated in
compensation for the cost of rifampicin resistance are not
conserved between these two species (MacLean RC, unpub-
lished data). This suggests that genetic background is likely to
play a more important role in molecular evolution over longer
time scales (see also Pelz et al. 2005; McCracken et al. 2009;
Powles and Yu 2010).
Due to the intensity of selection in our experiment, the
only possible mechanism of resistance was mutations in a
highly conserved domain of RNA polymerase (Campbell
et al. 2001). Speculatively, the impact of genetic background
on adaptation would have been much stronger if we had
used a weaker selective pressure, as this would have provided
more potential routes for adaptation. For example, recent
work has shown that mutations in many genes with diverse
functional roles can result in small increases in resistance
to antibiotics (Fajardo et al. 2008; Girgis et al. 2009).
Hypothetically, selection for resistance to an inhibitory
but sublethal dose could have resulted in a much broader
diversity of outcomes. This would be due to different strains
would have access to different routes to adaptation because
of their differing genomic contents. If this argument is correct,
then our estimate of the importance of genetic background
should be seen as a conservative estimate of the contribution
it can make to divergent responses to selection.
One key feature of our model system is that there are
many different substitutions that can drive the evolution of
resistance, making it possible for the probability of parallel
evolution to vary over a wide range. Alternatively, if only
a small number of substitutions could confer rifampicin
resistance, very high levels of parallel molecular evolution
would have been an almost guaranteed outcome of our ex-
periment. A similar argument can be made with regards to
the effect of horizontal gene transfer on parallel evolution.
Resistance to many antibiotics evolves by the acquisition
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of mobile genetic elements which carry resistance genes, such
as plasmids and lysogenic bacteriophages (reviewed in
Andersson and Hughes 2010). Because horizontal gene trans-
fer provides a vehicle for the movement of adaptive alleles
between lineages, it should increase the probability of parallel
molecular evolution. However, it is unclear if this will result in
increased levels of phenotypic parallelism, because in keeping
with the results present here, the fitness effect of acquiring a
plasmid is host-strain dependent (e.g., Mongkolrattanothai
et al. 2009; Humphrey et al. 2012; Sandegren et al. 2012).
Many of the most striking examples of parallel molecular
evolution across genetic backgrounds come from the evolu-
tion of resistance to toxins, such as insecticides (ffrench-
Constant et al. 2004), herbicides (Bernasconi et al. 1995),
and antibiotics (e.g., Jatsenko et al. 2010). Our study explores
the underlying mechanistic causes of adaption to rifampicin
in multiple strains of Pseudomonas, and it suggests that par-
allel phenotypic evolution is likely to be less common than
parallel molecular evolution. More generally, this study may
stimulate future work aimed at integrating comparative
approaches into experimental evolution.
Materials and Methods
Study System
The strains used, and their phylogenetic relatedness, is shown
in figure 1. Before the selection experiment all strains were
stored at 80C in 20% glycerol.
Selection Experiment
For each strain, 480 replicate populations were inoculated
with approximately 50 cells of a rifampicin sensitive ancestral
strain and grown for 48 h in 200ml of King’s B (KB) media at
30C with constant shaking at 200 rpm. Approximately 107
cells from each population were then plated onto KB-agar
containing rifampicin at the appropriate MIC (minimum
inhibitory concentration) for each strain (60mg/ml for
P. aeruginosa, 30mg/ml for all other strains). MICs had been
previously determined for each strain using standard meth-
ods as set by the European Committee for Antimicrobial
susceptibility testing. For each strain, a single colony was iso-
lated from 75 random populations that successfully evolved
rifampicin resistance. If less than 75 of the initial 480 popula-
tions produced at least one colony, additional selection
experiments were performed until 75 independent mutants
were achieved for each strain. Specifically, this involved
inoculating a further 480 populations for P. fluorescens Pf0-1
and a further 768 populations for P. fluorescens SBW25.Clones
were stored at 80C in 20% glycerol.
Sequencing
The rifampicin resistance-determining region (RRDR) of rpoB
was sequenced for each strain using the primers listed in
table 1. Purification of polymerase chain reaction (PCR) prod-
ucts was performed using ExoStar enzymes, and sequencing
was performed using BigDye terminator kit. Both were used
according to the manufacturer’s instructions. For populations
lacking mutations in this region, we sequenced a second
region of rpoB where rifampicin-resistant mutations are
known to occur, specifically the first 1,000 nt of rpoB.
Growth Rate Assay
To assay the extent of adaptation to selective conditions, we
measure the growth rate in the presence of rifampicin for
each evolved clone. Overnight cultures of resistant clones
were grown in KB supplemented with rifampicin (60mg/ml
for P. aeruginosa, 30mg/ml for all other strains) were diluted
2,000-fold into fresh rifampicin-supplemented medium and
incubated at 30C with constant shaking at 200 rpm. Viable
counts were taken every 2.5 h for 7.5 h. Viable cell counts were
performed using BacTiter-Glo kits (Promega, UK), which
quantifies the number of cells in a sample by measuring
adenosine triphosphate (ATP) content. Compared with the
more common optical density measures of cell density, these
kits have a larger dynamic range and can be used for strains
where optical density does not provide an accurate measure
of cell density. For example, under our laboratory conditions
some strains only achieve an optical density toward the very
end of their growth curves, and therefore exponential growth
rates could not be estimated from optical density data. This is
despite reaching a higher cell density than other strain which
do have an optical density. This is likely due to optical density
confounding cell density with cell size, fluorescent protein
content, biofilming, etc.
Growth rates were calculated as the Malthusian parameter,
and standardized to the growth rate for each wild-type strains
in the absence of rifampicin. The Malthusian parameter
is the natural log of ratio of the final density to the initial
density. As this is standardized to the ancestral value, this
provides the relative growth rate of each mutant, which is a
proxy for fitness. Each of the 600 rifampicin-resistant clones
Table 1. Oligonucleotides Used for PCR and Sequencing.
Rifampicin-Resistance Determining Region Other Region (First 500bp of rpoB)
Pseudomonas Aeruginosa 50-GTTCTTCAGCGCCGAGCG-30 50–ATGGCTTACTCATACACTGAG-30
50-GCGATGACGTGGTCGGC-30 50-CTCGATGCGCACGACCTG-30
P. protegens, P. stutzeri, P. fluorescens Pf0-1,
P. fulva, P. mendocina
50-CTGTTCAACAACCTGTTCTTC-30 50-AAAAAACGTATCCGCAAGGA-30
50-CGCGCCTTGACGGTGAATTCG-30 50-TCGATGTCGTTGGTGTACA-30
P. putida 50-CGTATCGGTCGTACCGAGATC-30 50-AAAAAACGTATCCGCAAGGA-30
50-CGCGCCTTGACGGTGAATTCG-30 50-TCGATGTCGTTGGTGTACA-30
P. fluorescens SBW25 50-CTGTTCAACAACCTGTTCTTC-30 50-AAAAAACGTATCCGCAAGGA-30
50-GGCGCCTTGACGGTGAACTCG-30 50-CGGAGATGAACGGACCGCAG-30
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were measured twice and we measured at least six replicate
cultures of the rifampicin sensitive strain from each strain.
For P. aeruginosa, this assay was repeated using both 30 and
60mg/ml. There was a strong correlation for fitness measured
in the two assays (df = 69, r= 0.541, P< 0.001) and no differ-
ence in mean fitness (paired t-test: t= 0.245, df = 70,
P= 0.807), demonstrating that the dosage of rifampicin did
not strongly affect the result of this assay.
Phylogenetic Reconstruction
To obtain an accurate phylogeny of the genus Pseudomonas,
we retrieved the nucleotide sequences of 55 housekeeping
genes (supplementary table S1, Supplementary Material
online) for 28 Pseudomonas genomes (supplementary fig.
S1, Supplementary Material online) plus Azotobacter vinelan-
dii from the Integrated Microbial Genomes database
(Markowitz et al. 2012) using reciprocal BLAST to make
sure of their orthology. Multiple alignments for all genes
were obtained using MUSCLE (Edgar 2004) and afterwards
trimmed with GBlocks (Castresana 2000) and concatenated
with SequenceMatrix (Vaidya et al. 2011). The resulting super-
matrix was then used to infer the nucleotide substitution
model using JModelTest 2 (Darriba et al. 2012). A maxi-
mum-likelihood (ML) phylogenetic tree was then inferred
assuming a GTR+G+I model with PHYML (Guindon et al.
2010). Additional trees inferred using Bayesian inference
and Neighbor Joining as well as a ML tree obtained with a
supermatrix of the protein sequences yielded identical topol-
ogies (data not shown). The relevant phylogeny for the eight
strains in this study system was then manually extracted.
Branch lengths are proportional to genetic distance and
all nodes on this phylogeny are strongly supported with at
least 99% confidence, as determined by an approximate log-
likelihood ratio test (Furio V, Maclean RC, unpublished
manuscript).
Analysis of Molecular Data
The probability of within-strain parallel molecular evolution
was calculated using Simpson’s index of concentration
(Simpson 1949), which measure the probability that two
randomly chosen clones from the same strain possess the
same mutation:
 ¼
Xn
i¼ 1
P2i
where Pi is the proportion of i-th mutation. This was calcu-
lated for each of our eight strains, from which the phyloge-
netically corrected mean was then calculated using
phylogenetically independent contrasts (Felsenstein 1985;
Garland et al. 1999).
We estimate the level of between strain parallel evolution
by first calculating Nei’s Gst (Nei 1973) and then standardiz-
ing it to Hedrick’s Gst’ (Hedrick and Goodnight 2005). Gst is a
measure of the genetic dissimilarity across multiple samples,
calculated by estimating the proportion of genetic diversity
due to differences in allele frequencies in different
subpopulations. Here, we use it in an analogous manner to
measure the proportion of genetic diversity due to different
mutation frequencies in different strains. Specifically, as we
are interested in the similarity of different mutation spectra,
here we use 1Gst’. A value of 0 would therefore indicate no
parallel evolution, whereas a value of 1 would indicate be-
tween-strain parallel evolution is as likely as within-strain par-
allel evolution.
Gst is calculated using the formula (Nei 1973):
Gst ¼ Ht  Hs
Ht
where Hs is mean within-strain diversity, which is equal to
1, and Ht is total diversity, which is calculated as:
Ht ¼
Xn
i¼ 1
P
2
i
Note that here we again use PICs to calculate the phylo-
genetically corrected mean proportion for each mutation.
This Gst was then standardized to Gst’ (Hedrick and
Goodnight 2005), using the formula:
Gst0 ¼ Gst K  1 þ Hsð Þ
K  1ð Þ 1  Hsð Þ
where K is the number of samples.
Associations between mutation spectrum, genome size,
and fitness, were performed using PICs using the method
of Felsenstein (Felsenstein 1985). PICs for genome size and
fitness were calculated as standard. Contrasts for mutation
spectrum between tips/nodes were calculated as squared dif-
ferences (as opposed to subtraction), with the rest of the PIC
procedure performed using standard methods.
The dendrogram of mutation spectrums was created using
the hierarchical clustering function in SPSS, with clusters
created based on the squared Euclidian distance between
groups.
Analyzing Phenotypic Diversity
Growth rate data was analyzed using a one-way ANOVA. To
control for phylogeny, the phylogenetically corrected mean
was used when calculating the amongst-group variance.
Supplementary Material
Supplementary material is available at Molecular Biology and
Evolution online (http://www.mbe.oxfordjournals.org/).
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